Namoc, Lolita U.
HRN: 03-17-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/19/2024
07/19/2024
IV
4.5gm
LD
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes